BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27376201)

  • 21. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
    Lode HN; Bruchelt G; Seitz G; Gebhardt S; Gekeler V; Niethammer D; Beck J
    Eur J Cancer; 1995; 31A(4):586-90. PubMed ID: 7576974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
    Carlin S; Mairs RJ; McCluskey AG; Tweddle DA; Sprigg A; Estlin C; Board J; George RE; Ellershaw C; Pearson AD; Lunec J; Montaldo PG; Ponzoni M; van Eck-Smit BL; Hoefnagel CA; van den Brug MD; Tytgat GA; Caron HN
    Clin Cancer Res; 2003 Aug; 9(9):3338-44. PubMed ID: 12960120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
    Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
    Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of organic cation transporter 3 (SLC22A3) and amphetamine.
    Zhu HJ; Appel DI; Gründemann D; Markowitz JS
    J Neurochem; 2010 Jul; 114(1):142-9. PubMed ID: 20402963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
    Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
    Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
    Blom T; Meinsma R; Rutgers M; Buitenhuis C; Dekken-Van den Burg M; van Kuilenburg ABP; Tytgat GAM
    EJNMMI Res; 2020 Jul; 10(1):78. PubMed ID: 32642907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Novel Antidepressants on Cardiac
    Werner RA; Kobayashi R; Javadi MS; Köck Z; Wakabayashi H; Unterecker S; Nakajima K; Lapa C; Menke A; Higuchi T
    J Nucl Med; 2018 Jul; 59(7):1099-1103. PubMed ID: 29496989
    [No Abstract]   [Full Text] [Related]  

  • 28. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
    Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
    Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
    J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage.
    He Y; Das B; Baruchel S; Kumar P; Wiebe L; Reilly RM
    Nucl Med Commun; 2004 Nov; 25(11):1125-30. PubMed ID: 15577592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.
    Vaidyanathan G; Friedman HS; Keir ST; Zalutsky MR
    Br J Cancer; 1996 May; 73(10):1171-7. PubMed ID: 8630274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
    Armour A; Mairs RJ; Gaze MN; Wheldon TE
    Br J Cancer; 1994 Sep; 70(3):445-8. PubMed ID: 8080728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
    Montaldo PG; Raffaghello L; Guarnaccia F; Pistoia V; Garaventa A; Ponzoni M
    Int J Cancer; 1996 Jul; 67(1):95-100. PubMed ID: 8690531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
    Lashford LS; Hancock JP; Kemshead JT
    Int J Cancer; 1991 Jan; 47(1):105-9. PubMed ID: 1985865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
    Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
    Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
    Babich JW; Graham WA; Fischman AJ
    Br J Cancer; 1996 Sep; 74(6):917-24. PubMed ID: 8826858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
    Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
    J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
    DuBois SG; Mody R; Naranjo A; Van Ryn C; Russ D; Oldridge D; Kreissman S; Baker DL; Parisi M; Shulkin BL; Bai H; Diskin SJ; Batra V; Maris JM; Park JR; Matthay KK; Yanik G
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.
    Kölby L; Bernhardt P; Levin-Jakobsen AM; Johanson V; Wängberg B; Ahlman H; Forssell-Aronsson E; Nilsson O
    Br J Cancer; 2003 Oct; 89(7):1383-8. PubMed ID: 14520475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.